This article is part of your HHCN+ membership.
As we head into 2020—the first year of the patient-led grouping model (PDGM)—many thought a breakdown in home therapy was inevitable.
More than three years later, it is still unclear exactly how PDGM has affected therapeutics and how the industry can differentiate the impact of PDGM from the impact of the pandemic. More clarity should come in the next few months, two of the largest therapeutic associations in the US told Home Health Care News.
Subscribe to HHCN+ to read this exclusive content.
Individual membership $400 per year
Group 2–5 members $380 per year*
Need more than 5 participants? For more information please contact us.
* per member